Daniel Ramón, Ph.D., attained his doctorate while working at the department of molecular genetics of the pharmaceutical company Antibióticos S.A. He then moved to the University of Wageningen in the Netherlands for post-doctoral studies. Ramón was professor of food technology at both the National Spanish Research Council (CSIC) and the University of Valencia. He currently serves as vice president of research and development (R&D), health & wellness, at Archer Daniels Midland Co. (ADM), as well as director of Biopolis, a microbial biotech company subsidiary of ADM. Ramón has authored 150 articles in peer-reviewed journals and co-authored more than 100 patents.
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023
More bioavailable hyaluronic acid complex for today’s beauty-from-within consumer – snapshotSep 18, 2023